Quick Takeaways
- John Furey has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $88,189.
- Recent insider filing activity is available below.
Insider Trading & Ownership of John Furey
- Location
- San Carlos, CA
- Summary
- The estimated net worth of John Furey is at least $88,189 dollars as of 16 Jun 2025. John Furey is the Director of Vaxcyte, Inc. and owns shares of Vaxcyte, Inc. (PCVX) stock worth about $88.2K.
- Signature
- John Furey, by /s/ Peter N. Efremenko, Attorney-In-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Furey and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Vaxcyte, Inc. ($88,189).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of John Furey
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Director | $88,189 | 12 Jun 2025 | ||
| ADAP | Adaptimmune Therapeutics PLC | Director | 01 Jul 2024 |
Insider Transactions Reported by John Furey:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.